Areas of Expertise:
Retinopathy of prematurity, Visual development, Pediatric ophthalmology
Graham Quinn, MD, MSCE, is the Emeritus Director of Research in the Division of Pediatric Ophthalmology at Children's Hospital of Philadelphia. He is also an Emeritus Professor of Ophthalmology at the University of Pennsylvania.
Dr. Quinn received his medical degree from Duke University School of Medicine in 1973. He completed an internship in internal medicine and a year of pathology residency at Case Western Reserve University in Cleveland before moving to Philadelphia to complete his residency in ophthalmology at Penn. He did his fellowship training at The Children's Hospital of Philadelphia and stayed on as a member of the faculty in the Department of Ophthalmology at the University of Pennsylvania. Dr. Quinn completed the master's of science degree in Clinical Epidemiology and Biostatistics at the University of Pennsylvania.
Dr. Quinn's interest areas are retinopathy of prematurity (ROP) and visual and ocular development in children. He was a principal investigator and member of the executive and editorial committees of the landmark CRYO-ROP study and PI of the Philadelphia center and worked with Velma Dobson, PhD in the Vision Testing center for ETROP. He served as a member of the original group that developed the International Classification of ROP and recently chaired a “revisiting” of the classification. He has participated in a large number of international conferences and workshops on ROP prevention and treatment in countries with rapidly developing neonatal care systems. Recent work has concentrated on early markers identifying at risk babies and also telemedicine in ROP.
As a consequence of the abnormal refractive errors that are frequently seen in premies, Dr. Quinn developed an interest in ocular growth and development and has established a collaborative clinical research effort in the Division focusing on the development of refractive error and patterns of ocular growth in children.
Duke University School of Medicine, Durham, NC
Cleveland Metropolitan General Hospital, Case Western Reserve University, Cleveland, Ohio
Scheie Eye Institute, Philadelphia, Pa.
The Children's Hospital of Philadelphia, Philadelphia, Pa.
American Board of Ophthalmology
Emeritus Director of Research
Emeritus Professor of Ophthalmology at the University of Pennsylvania
Retinopathy of Prematurity
Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, Ying GS; G-ROP Study Group. Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study. JAMA Ophthalmol. 2018;136(9):1034-1040.
Jensen AK, Ying GS, Huang J, Quinn GE, Binenbaum G. Longitudinal study of the association between thrombocytopenia and retinopathy of prematurity. J AAPOS. 2018;22(2):119-123.
Ying GS, VanderVeen D, Daniel E, Quinn GE, Baumritter A; e-ROP Cooperative Group. Risk score for predicting treatment-requiring retinopathy of prematurity (ROP) in the telemedicine approaches to evaluating acute-phase ROP Study. Ophthalmology. 2016 Oct;123(10):2176-82.
Jensen AK, Ying GS, Huang J, Quinn GE, Binenbaum G. Postnatal serum insulin-like growth factor I and retinopathy of prematurity. Retina. 2016 Aug 12.
Quinn GE, Barr C, Bremer D, Fellows R, Gong A, Hoffman R, Repka MX, Shepard J, Siatkowski RM, Wade K, Ying GS. Changes in course of retinopathy of prematurity from 1986 to 2013: comparison of three studies in the United States. Ophthalmology. 2016 Jul;123(7):1595-600.
Quinn GE, Darlow BA. Concerns for development after bevacizumab treatment of ROP. Pediatrics. 2016 Apr;137(4).
Kemper AR, Prosser LA, Wade KC, Repka MX, Ying GS, Baumritter A, Quinn GE; e-ROP Study Cooperative Group. A comparison of strategies for retinopathy of prematurity detection. Pediatrics. 2016 Jan;137(1).
Daniel E, Quinn GE, Hildebrand PL, Ells A, Hubbard GB 3rd, Capone A Jr, Martin ER, Ostroff CP, Smith E, Pistilli M, Ying GS; e-ROP Cooperative Group. Validated System for Centralized Grading of Retinopathy of Prematurity: Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study. JAMA Ophthalmol. 2015 Jun;133(6):675-82. doi: 10.1001/jamaophthalmol.2015.0460.
Ying GS, Quinn GE, Wade KC, Repka MX, Baumritter A, Daniel E; e-ROP Cooperative Group. Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study. JAMA Ophthalmol. 2015 Mar;133(3):304-11. doi: 10.1001/jamaophthalmol.2014.5185.
Kemper AR, Wade KC, Hornik CP, Ying GS, Baumritter A, Quinn GE; Telemedicine Approaches to Evaluating Acute-phase Retinopathy of Prematurity (e-ROP) Study Cooperative Group. Retinopathy of prematurity risk prediction for infants with birth weight less than 1251 grams. J Pediatr. 2015 Feb;166(2):257-61.e2. doi: 10.1016/j.jpeds.2014.09.069. Epub 2014 Nov 12.
Quinn GE, Ying GS, Daniel E, Hildebrand PL, Ells A, Baumritter A, Kemper AR, Schron EB, Wade K; e-ROP Cooperative Group. Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. JAMA Ophthalmol. 2014 Oct;132(10):1178-84. doi: 10.1001/jamaophthalmol.2014.1604.